RTI Surgical (“RTI” or “the Company”), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announces it has successfully completed the acquisition of Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue, as announced on October 7, 2024. The acquisition further expands RTI’s uniquely comprehensive portfolio of allograft and xenograft biomaterials at scale, building on the Company’s acquisition of Cook Biotech earlier in the year.
Read the full article: RTI Surgical Completes Acquisition of Collagen Solutions //
Source: https://www.globenewswire.com/news-release/2024/11/01/2973355/0/en/RTI-Surgical-Completes-Acquisition-of-Collagen-Solutions.html